VIR Vir Biotechnology, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 5, 2026
$11.17
· of 52w range
· above low
· to high
$4.8252w low
$11.9452w high
Market Cap (MRQ)
$1.89B
P/E (TTM)
-6.0
EPS (TTM)
$-1.86
Revenue (TTM)
$303M
your badges
52W Range
$5–$12
Analyst Rating
BUY
Price Target
$21
P/E
-6.0
ROE
-26.1%
Net Profit Margin
-83.0%
Your badge strip is empty — pin a metric anywhere on this page.
VIR Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$11.17
Market Cap (MRQ)
$1.89B
P/E (TTM)
-6.0
EPS (TTM)
$-1.86
Revenue (TTM)
$303M
ROE (TTM)
-26.1%
52W Range
$5–$12
VIR Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
About Vir Biotechnology, Inc. - Common Stock Company overview from Wikipedia
sectorHealthcare
industryBiotechnology
employees367
countryUS
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$69M2017-12-31 → 2025-12-31
EPS$-3.162019-12-31 → 2025-12-31
Free Cash Flow$-397M2019-12-31 → 2025-12-31
Net margin-83.0%2019-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | VIR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | -6.05Y avg ≈2.2 | ≈2.2 | · | · | |
| P/S (TTM) | 6.25Y avg ≈9.7 | ≈9.7 | 7.4 | Undervalued | |
| P/B (MRQ) | 1.95Y avg ≈1.7 | ≈1.7 | 3.8 | Undervalued | |
| Price / FCF (TTM) | -9.35Y avg ≈-16.6 | ≈-16.6 | · | · | |
| Price / Cash Flow (TTM) | -9.35Y avg ≈-23.9 | ≈-23.9 | · | · | |
| Price / Tangible Book (MRQ) | 1.95Y avg ≈1.7 | ≈1.7 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | VIR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin (TTM) | -92.4%5Y avg ≈-438.9% | ≈-438.9% | -171.9% | Top tier | |
| EBITDA Margin (TTM) | -88.6%5Y avg ≈-427.0% | ≈-427.0% | -171.9% | Top tier | |
| Pretax Margin (TTM) | -82.9%5Y avg ≈-395.1% | ≈-395.1% | -91.1% | Top tier | |
| Net Profit Margin (TTM) | -83.0%5Y avg ≈-395.2% | ≈-395.2% | -159.6% | Top tier | |
| ROA (TTM) | -20.9%5Y avg ≈-7.1% | ≈-7.1% | -32.2% | In line | |
| ROE (TTM) | -26.1%5Y avg ≈-12.5% | ≈-12.5% | -58.3% | Top tier | |
| ROIC | -62.7%5Y avg ≈-20.0% | ≈-20.0% | -62.7% | In line |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | VIR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 6.05Y avg ≈6.6 | ≈6.6 | 6.3 | In line | |
| Quick Ratio | 5.05Y avg ≈5.9 | ≈5.9 | 5.1 | In line |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | VIR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | -7.6%5Y avg ≈253.1% | ≈253.1% | · | · | |
| Revenue CAGR 3Y | -65.1%5Y avg ≈-40.1% | ≈-40.1% | · | · | |
| Revenue CAGR 5Y | -2.1% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | VIR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.15Y avg ≈0.3 | ≈0.3 | 0.1 | Weak | |
| Revenue / Employee | ≈$186.8K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-125.6%
Next Report
Nov 03, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 4, 2026 | $0.47 | $0.34 | 39.8% |
| March 31, 2026 | $-0.85 | $-0.10 | -781.7% | |
| Dec. 31, 2025 | $-0.31 | $-0.50 | 37.6% | |
| Sept. 30, 2025 | $-1.17 | $-0.86 | -35.7% | |
| June 30, 2025 | $-0.80 | $-0.73 | -9.5% | |
| March 31, 2025 | $-0.88 | $-0.84 | -4.3% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $69M | $74M | $86M | $1.62B | $1.10B | $76M | $8M | $11M | |
| Cost of Revenue | $26.0K | $845.0K | $3M | $146M | $66M | $0 | $0 | · | |
| R&D Expense | $456M | $506M | $580M | $475M | $448M | $302M | $148M | $100M | |
| SG&A Expense | $92M | $119M | $174M | $162M | $161M | $71M | $38M | $29M | |
| Operating Expenses | $548M | $661M | $770M | $783M | $675M | $373M | $186M | $129M | |
| Operating Income | $-479M | $-587M | $-684M | $833M | $421M | $-297M | $-178M | $-119M | |
| Interest Income | $40M | $72M | $87M | $28M | · | · | $9M | $3M | |
| Other Non-op | $-409.0K | $-2M | $-9M | $4M | $-9M | $-4M | $-5M | $-212.0K | |
| Pretax Income | $-438M | $-523M | $-628M | $754M | $550M | $-299M | $-175M | $-116M | |
| Income Tax | $217.0K | $-1M | $-13M | $238M | $21M | $54.0K | $154.0K | $-480.0K | |
| Net Income | $-438M | $-522M | $-615M | $516M | $529M | $-299M | $-175M | $-116M | |
| EPS (Basic) | $-3.16 | $-3.83 | $-4.59 | $3.89 | $4.07 | $-2.51 | $-5.76 | · | |
| EPS (Diluted) | $-3.16 | $-3.83 | $-4.59 | $3.83 | $3.96 | $-2.51 | $-5.76 | · | |
| Shares (Basic) | 138,520,419 | 136,246,865 | 134,130,924 | 132,606,767 | 129,884,967 | 119,159,424 | 30,349,920 | · | |
| Shares (Diluted) | 138,520,419 | 136,246,865 | 134,130,924 | 134,810,908 | 133,437,126 | 119,159,424 | 30,349,920 | · | |
| EBITDA | $-468M | $-573M | $-665M | $839M | $426M | $-293M | $-175M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $232M | $223M | $242M | $849M | $348M | $437M | $109M | $48M | |
| Short-term Investments | $229M | $678M | $1.27B | $1.52B | $217M | $300M | $274M | $51M | |
| Receivables | · | · | · | $0 | $773M | $0 | · | · | |
| Prepaid Expense | $45M | $48M | $53M | $104M | $73M | $28M | $13M | $9M | |
| Other Current Assets | · | $100.0K | $8M | $26M | · | · | · | · | |
| Current Assets | $514M | $1.04B | $1.59B | $2.52B | $1.56B | $772M | $403M | $118M | |
| PP&E (Net) | $56M | $63M | $96M | $106M | $43M | $18M | $16M | $12M | |
| PP&E (Gross) | $103M | $100M | $130M | $126M | $57M | $27M | $21M | $14M | |
| Accum. Depreciation | $47M | $37M | $34M | $21M | $14M | $9M | $5M | $2M | |
| Goodwill | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | |
| Intangibles | $8M | $8M | $23M | $33M | $33M | $34M | $36M | $37M | |
| Total Assets | $1.00B | $1.40B | $1.92B | $2.80B | $1.95B | $919M | $512M | $192M | |
| Accounts Payable | $10M | $5M | $6M | $6M | $7M | $5M | $6M | $6M | |
| Accrued Liabilities | · | · | · | · | · | · | $26M | $15M | |
| Current Liabilities | $93M | $120M | $175M | $511M | $341M | $99M | $59M | $40M | |
| Capital Leases | $89M | $90M | $112M | $124M | $134M | $67M | · | · | |
| Deferred Tax | · | · | · | $3M | $18M | $3M | $3M | · | |
| Other Non-current Liabilities | $22M | $15M | $16M | $11M | $3M | $4M | $4M | $2M | |
| Total Liabilities | $238M | $248M | $329M | $724M | $522M | $202M | $88M | $62M | |
| Common Stock | $14.0K | $14.0K | $13.0K | $13.0K | $13.0K | $13.0K | $11.0K | $1.0K | |
| Paid-in Capital | $1.97B | $1.91B | $1.83B | $1.71B | $1.57B | $1.39B | $793M | $15M | |
| Retained Earnings | $-1.20B | $-760M | $-238M | $377M | $-139M | $-667M | $-369M | $-194M | |
| AOCI | $-2M | $-2M | $-815.0K | $-9M | $-1M | $-1M | $-601.0K | $-14.0K | |
| Stockholders' Equity | $765M | $1.15B | $1.59B | $2.08B | $1.43B | $717M | $424M | $-179M | |
| Liabilities + Equity | $1.00B | $1.40B | $1.92B | $2.80B | $1.95B | $919M | $512M | $192M | |
| Shares Outstanding | 139,474,954 | 136,959,446 | 134,781,286 | 133,236,687 | 131,161,404 | 127,416,740 | 107,648,925 | 8,858,799 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $12M | $15M | $19M | $7M | $5M | $4M | $3M | $2M | |
| Stock-based Comp | $49M | $78M | $111M | $102M | $84M | $28M | $9M | $5M | |
| Deferred Tax | $304.0K | $-3M | $-1M | $-15M | $15M | $-52.0K | · | $-500.0K | |
| Amort. of Intangibles | · | · | $531.0K | $532.0K | $533.0K | $1M | $1M | $1M | |
| Restructuring | · | $35M | $14M | · | · | · | · | · | |
| Other Non-cash | $-15M | $-14M | $-293M | $1.05B | $-680M | $76M | $33M | · | |
| Operating Cash Flow | $-392M | $-446M | $-779M | $1.66B | $-48M | $-191M | $-130M | $-94M | |
| CapEx | $5M | $7M | $22M | $68M | $22M | $7M | $9M | $8M | |
| Investing Cash Flow | $310M | $499M | $165M | $-1.19B | $-141M | $-10M | $-256M | $-60M | |
| Stock Issued | · | · | · | $0 | $0 | $323M | $126M | · | |
| Net Stock Activity | · | · | · | $0 | · | $323M | $126M | · | |
| Financing Cash Flow | $4M | $4M | $7M | $35M | $100M | $529M | $449M | $25M | |
| Net Change in Cash | $-78M | $57M | $-607M | $505M | $-88M | $329M | $63M | $-130M | |
| Taxes Paid | $2M | $786.0K | $3M | $-252M | $0 | $0 | · | · | |
| Free Cash Flow | $-397M | $-454M | $-800M | $1.60B | $-69M | $-197M | $-139M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -699.2% | -791.3% | -794.0% | 51.6% | 38.4% | -388.9% | -2199.7% | · | |
| Net Margin | -638.9% | -703.4% | -713.8% | 31.9% | 48.2% | -391.1% | -2159.0% | · | |
| Pretax Margin | -638.6% | -705.0% | -728.9% | 46.7% | 50.2% | -391.0% | -2157.1% | · | |
| EBITDA Margin | -682.1% | -771.6% | -772.1% | 51.9% | 38.9% | -383.1% | -2159.0% | · | |
| ROA | -36.5% | -31.5% | -26.1% | 21.7% | 36.8% | -41.8% | -49.6% | · | |
| ROE | -51.1% | -43.7% | -37.7% | 24.4% | 45.8% | -39.1% | -244.1% | · | |
| ROIC | -62.7% | -50.9% | -42.1% | 27.4% | 28.2% | -41.4% | -42.0% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.5 | 8.7 | 9.1 | 4.9 | 4.6 | 7.8 | 6.8 | · | |
| Quick Ratio | 5.0 | 7.5 | 8.6 | 4.6 | 3.9 | 7.4 | 6.5 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.0 | 0.0 | 0.7 | 0.8 | 0.1 | 0.0 | · | |
| Receivables Turnover | · | · | · | 4.2 | 2.8 | · | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.49 | $8.40 | $11.80 | $15.60 | $10.92 | $5.63 | $3.94 | · | |
| Revenue / Share | $0.49 | $0.54 | $0.64 | $11.99 | $8.21 | · | · | · | |
| Cash Flow / Share | $-2.83 | $-3.28 | $-5.81 | $12.34 | $-0.36 | · | · | · | |
| Cash / Share | $1.66 | $1.63 | $1.79 | $6.37 | $2.65 | $3.43 | $1.02 | · | |
| EPS (TTM) | $-3.16 | $-3.83 | $-4.59 | $3.83 | $3.96 | $-2.51 | $-5.76 | · |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -7.6% | -13.9% | -94.7% | 47.5% | 1334.4% | · | · | · | |
| Revenue CAGR 3Y | -65.1% | -59.2% | 4.1% | · | · | · | · | · | |
| Revenue CAGR 5Y | -2.1% | · | · | · | · | · | · | · | |
| EPS YoY | · | · | · | -3.3% | · | · | · | · | |
| Net Income YoY | · | · | · | -2.4% | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $69M | $74M | $86M | $1.62B | $1.10B | $76M | $8M | · | |
| Net Income TTM | $-438M | $-522M | $-615M | $516M | $529M | $-299M | $-175M | · | |
| Market Cap | $841M | $1.01B | $1.36B | $3.37B | $5.49B | $3.41B | $1.35B | · | |
| P/E | -1.9 | -1.9 | -2.2 | 6.6 | 10.6 | -10.7 | -2.2 | · | |
| P/S | 12.3 | 13.5 | 15.7 | 2.1 | 5.0 | 44.7 | 167.3 | · | |
| P/B | 1.1 | 0.9 | 0.9 | 1.6 | 3.8 | 4.8 | 3.2 | · | |
| P / Tangible Book | 1.1 | 0.9 | 0.9 | 1.7 | 4.0 | 5.1 | · | · | |
| P / Cash Flow | -2.1 | -2.3 | -1.7 | 2.0 | -115.4 | -17.9 | -10.4 | · | |
| P / FCF | -2.1 | -2.2 | -1.7 | 2.1 | -79.1 | -17.3 | -9.8 | · | |
| Earnings Yield | -52.4% | -52.2% | -45.6% | 15.1% | 9.5% | -9.4% | -45.8% | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $239M | $-29.0K | $64M | $240.0K | $1M | $3M | $12M | $2M | $3M | $56M | $17M | $3M | $4M | $63M | $49M | $375M | |
| Cost of Revenue | $0 | · | · | · | $11.0K | $0 | $684.0K | $50.0K | $52.0K | $59.0K | $798.0K | $38.0K | $22.0K | $2M | $6M | $22M | |
| R&D Expense | $135M | $109M | $88M | $151M | $98M | $119M | $106M | $195M | $105M | $100M | $109M | $145M | $168M | $158M | $155M | $114M | |
| SG&A Expense | $30M | $23M | $24M | $22M | $22M | $24M | $27M | $26M | $30M | $36M | $41M | $41M | $46M | $47M | $39M | $43M | |
| Operating Expenses | $165M | $132M | $112M | $174M | $120M | $143M | $130M | $234M | $162M | $136M | $156M | $189M | $219M | $206M | $200M | $180M | |
| Operating Income | $73M | $-132M | $-48M | $-173M | $-118M | $-140M | $-117M | $-231M | $-159M | $-80M | $-139M | $-187M | $-215M | $-143M | $-151M | $195M | |
| Interest Income | $9M | $7M | $8M | $9M | $11M | $12M | $14M | $18M | $19M | $21M | $21M | $22M | · | · | · | · | |
| Other Non-op | $-451.0K | $-254.0K | $-335.0K | $-228.0K | $226.0K | $-72.0K | $-506.0K | $-893.0K | $-535.0K | $-287.0K | $-1M | $882.0K | $-367.0K | $-8M | $-26M | $27M | |
| Pretax Income | $80M | $-126M | $-43M | $-163M | $-111M | $-121M | $-105M | $-214M | $-140M | $-65M | $-121M | $-167M | $-198M | $-143M | $-152M | $218M | |
| Income Tax | $179.0K | $170.0K | $-137.0K | $168.0K | $170.0K | $16.0K | $-86.0K | $177.0K | $-2M | $276.0K | $-5M | $-3M | $-3M | $-2M | $-50M | $42M | |
| Net Income | $80M | $-126M | $-43M | $-163M | $-111M | $-121M | $-105M | $-214M | $-138M | $-65M | $-116M | $-163M | $-195M | $-141M | $-102M | $175M | |
| EPS (Basic) | $0.48 | $-0.85 | $-0.31 | $-1.17 | $-0.80 | $-0.88 | $-0.77 | $-1.56 | $-1.02 | $-0.48 | $-0.86 | $-1.22 | $-1.45 | $-1.06 | $-0.78 | $1.32 | |
| EPS (Diluted) | $0.47 | $-0.85 | $-0.31 | $-1.17 | $-0.80 | $-0.88 | $-0.77 | $-1.56 | $-1.02 | $-0.48 | $-0.86 | $-1.22 | $-1.45 | $-1.06 | $-0.74 | $1.30 | |
| Shares (Basic) | 167,719,015 | 147,356,811 | · | 138,930,173 | 138,447,469 | 137,468,900 | · | 136,653,753 | 136,223,725 | 135,280,648 | · | 134,289,620 | 134,059,079 | 133,552,839 | · | 132,729,530 | |
| Shares (Diluted) | 168,879,127 | 147,356,811 | · | 138,930,173 | 138,447,469 | 137,468,900 | · | 136,653,753 | 136,223,725 | 135,280,648 | · | 134,289,620 | 134,059,079 | 133,552,839 | · | 134,963,317 | |
| EBITDA | $73M | $-129M | · | $-173M | $-118M | $-137M | · | $-231M | $-159M | $-76M | · | $-182M | $-211M | $-138M | · | $197M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $279M | $274M | $232M | $170M | $211M | $274M | $223M | $168M | $297M | $161M | $242M | $452M | $667M | $825M | $849M | $964M | |
| Short-term Investments | $250M | $196M | $229M | $328M | $388M | $517M | $678M | $741M | $850M | $985M | · | $1.23B | $1.17B | $1.41B | · | $1.36B | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Prepaid Expense | $39M | $45M | $45M | $37M | $41M | $42M | $48M | $43M | $41M | $50M | · | $59M | $86M | $98M | · | $54M | |
| Other Current Assets | · | · | · | · | · | · | · | $0 | $1M | $4M | · | $5M | $13M | $18M | · | · | |
| Current Assets | $574M | $523M | $514M | $546M | $736M | $932M | $1.04B | $1.05B | $1.21B | $1.21B | · | $1.77B | $1.95B | $2.36B | · | $2.41B | |
| PP&E (Net) | $50M | $53M | $56M | $58M | $61M | $62M | $63M | $65M | $66M | $92M | · | $99M | $104M | $104M | · | $100M | |
| PP&E (Gross) | $103M | $103M | $103M | $103M | $102M | $101M | $100M | $100M | $99M | $131M | · | $129M | $130M | $130M | · | $119M | |
| Accum. Depreciation | $53M | $50M | $47M | $44M | $42M | $39M | $37M | $35M | $33M | $38M | · | $30M | $26M | $26M | · | $19M | |
| Goodwill | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | · | $17M | $17M | $17M | · | $17M | |
| Intangibles | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $19M | $19M | $22M | · | $25M | $26M | $33M | · | $33M | |
| Total Assets | $1.21B | $1.03B | $1.00B | $1.02B | $1.19B | $1.31B | $1.40B | $1.50B | $1.67B | $1.79B | · | $2.04B | $2.24B | $2.67B | · | $2.70B | |
| Accounts Payable | $18M | $5M | $10M | $7M | $12M | $4M | $5M | $7M | $4M | $7M | · | $4M | $12M | $12M | · | $3M | |
| Current Liabilities | $95M | $74M | $93M | $75M | $105M | $137M | $120M | $117M | $96M | $94M | · | $165M | $226M | $485M | · | $308M | |
| Capital Leases | $84M | $87M | $89M | $91M | $93M | $88M | $90M | $93M | $95M | $109M | · | $114M | $118M | $121M | · | $127M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | $3M | · | $18M | |
| Other Non-current Liabilities | $19M | $19M | $22M | $13M | $13M | $15M | $15M | $14M | $14M | $14M | · | $13M | $12M | $8M | · | $7M | |
| Total Liabilities | $232M | $213M | $238M | $223M | $245M | $264M | $248M | $258M | $236M | $247M | · | $370M | $434M | $695M | · | $546M | |
| Common Stock | $17.0K | $16.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | · | $13.0K | $13.0K | $13.0K | · | $13.0K | |
| Paid-in Capital | $2.23B | $2.14B | $1.97B | $1.95B | $1.94B | $1.93B | $1.91B | $1.89B | $1.88B | $1.85B | · | $1.80B | $1.77B | $1.74B | · | $1.68B | |
| Retained Earnings | $-1.24B | $-1.32B | $-1.20B | $-1.15B | $-992M | $-881M | $-760M | $-655M | $-441M | $-303M | · | $-122M | $42M | $236M | · | $479M | |
| AOCI | $-5M | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $1M | $-3M | $-2M | · | $-2M | $-3M | $-3M | · | $-12M | |
| Stockholders' Equity | $982M | $813M | $765M | $796M | $947M | $1.04B | $1.15B | $1.24B | $1.43B | $1.55B | $1.59B | $1.68B | $1.81B | $1.97B | $2.08B | $2.15B | |
| Liabilities + Equity | $1.21B | $1.03B | $1.00B | $1.02B | $1.19B | $1.31B | $1.40B | $1.50B | $1.67B | $1.79B | · | $2.04B | $2.24B | $2.67B | · | $2.70B | |
| Shares Outstanding | 169,185,671 | 161,234,058 | 139,474,954 | 139,022,594 | 138,886,274 | 138,063,698 | 136,959,446 | 136,706,350 | 136,590,097 | 135,843,560 | 134,781,286 | 134,497,886 | 134,230,494 | 133,930,957 | 133,236,687 | 133,027,358 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $5M | $5M | $4M | $5M | $6M | $2M | $2M | |
| Stock-based Comp | $12M | $12M | $11M | $11M | $12M | $14M | $16M | $17M | $22M | $24M | $28M | $27M | $31M | $25M | $25M | $25M | |
| Deferred Tax | · | · | · | · | · | · | $-3M | $57.0K | · | · | $-1M | $0 | · | · | · | · | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | · | $133.0K | $133.0K | $133.0K | · | $133.0K | |
| Restructuring | · | · | · | · | · | · | $-4M | $13M | $26M | $-48.0K | · | · | · | · | · | · | |
| Other Non-cash | · | $-22M | · | · | · | $26M | · | · | · | $-72M | · | · | · | $-16M | · | · | |
| Operating Cash Flow | $123M | $-132M | $-26M | $-168M | $-120M | $-78M | $-88M | $-171M | $-78M | $-109M | $-108M | $-156M | $-389M | $-126M | $35M | $118M | |
| CapEx | $32.0K | $390.0K | $348.0K | $317.0K | $3M | $2M | $2M | $3M | $666.0K | $2M | $2M | $4M | $9M | $7M | $13M | $19M | |
| Investing Cash Flow | $-197M | $12M | $87M | $40M | $56M | $127M | $141M | $119M | $212M | $28M | $-105M | $-59M | $230M | $98M | $-153M | $-663M | |
| Stock Issued | · | $162M | · | · | · | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $162M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $78M | $163M | $1M | $102.0K | $2M | $598.0K | $1M | $31.0K | $3M | $152.0K | $2M | $277.0K | $3M | $2M | $2M | $2M | |
| Net Change in Cash | $5M | $42M | $62M | $-127M | $-62M | $49M | $54M | $-53M | $137M | $-81M | $-211M | $-215M | $-156M | $-25M | $-116M | $-543M | |
| Taxes Paid | · | · | $154.0K | $5M | · | · | · | $0 | · | · | · | · | · | · | $-444M | $102M | |
| Free Cash Flow | · | $-133M | · | · | · | $-80M | · | · | · | $-111M | · | · | · | $-133M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 30.8% | 456172.4% | · | -72267.9% | -9754.3% | -4602.5% | · | -9718.7% | -5158.7% | -142.1% | · | -7075.9% | -5667.3% | -227.7% | · | 52.0% | |
| Net Margin | 33.5% | 433431.0% | · | -67975.4% | -9139.9% | -3989.6% | · | -8979.7% | -4500.1% | -115.8% | · | -6192.2% | -5129.7% | -223.9% | · | 46.8% | |
| Pretax Margin | 33.6% | 432844.8% | · | -67905.4% | -9125.9% | -3989.1% | · | -8972.3% | -4549.3% | -115.3% | · | -6314.0% | -5204.7% | -227.4% | · | 58.1% | |
| EBITDA Margin | 30.8% | 446479.3% | · | -72267.9% | -9754.3% | -4507.9% | · | -9718.7% | -5158.7% | -134.0% | · | -6905.3% | -5546.1% | -219.0% | · | 52.5% | |
| ROA | 6.7% | -10.8% | · | -13.0% | -7.8% | -7.8% | · | -12.1% | -7.1% | -2.9% | · | -6.9% | -8.0% | -5.1% | · | 9.0% | |
| ROE | 8.3% | -13.5% | · | -16.0% | -9.3% | -9.3% | · | -14.7% | -8.5% | -3.7% | · | -8.5% | -10.3% | -7.1% | · | 11.6% | |
| ROIC | 7.5% | -16.3% | · | -21.8% | -12.5% | -13.4% | · | -18.7% | -10.9% | -5.2% | · | -10.9% | -11.7% | -7.2% | · | 7.3% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.0 | 7.1 | · | 7.3 | 7.0 | 6.8 | · | 8.9 | 12.5 | 12.9 | · | 10.7 | 8.6 | 4.9 | · | 7.8 | |
| Quick Ratio | 5.6 | 6.4 | · | 6.6 | 5.7 | 5.8 | · | 7.8 | 11.9 | 12.2 | · | 10.2 | 8.1 | 4.6 | · | 7.5 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.2 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 8.1 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.81 | $5.04 | · | $5.73 | $6.82 | $7.56 | · | $9.08 | $10.50 | $11.39 | · | $12.45 | $13.49 | $14.71 | · | $16.16 | |
| Revenue / Share | $1.41 | $-0.00 | · | $0.00 | $0.01 | $0.02 | · | $0.02 | $0.02 | $0.42 | · | $0.02 | $0.03 | $0.47 | · | $2.78 | |
| Cash Flow / Share | · | $-0.90 | · | · | · | $-0.57 | · | · | · | $-0.81 | · | · | · | $-0.94 | · | · | |
| Cash / Share | $1.65 | $1.70 | · | $1.22 | $1.52 | $1.98 | · | $1.23 | $2.17 | $1.18 | · | $3.36 | $4.97 | $6.16 | · | $7.24 | |
| EPS (TTM) | $-1.86 | $-3.13 | · | $-3.62 | $-4.01 | $-4.23 | · | $-3.92 | $-3.58 | $-4.01 | · | $-4.47 | $-1.95 | $-1.08 | · | $8.57 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $303M | $65M | · | $17M | $19M | $21M | · | $79M | $79M | $80M | · | $119M | $491M | $446M | · | $2.38B | |
| Net Income TTM | $-252M | $-443M | · | $-500M | $-550M | $-578M | · | $-533M | $-483M | $-539M | · | $-601M | $-262M | $-144M | · | $1.14B | |
| Market Cap | $1.72B | $1.44B | · | $794M | $700M | $895M | · | $1.02B | $1.22B | $1.38B | · | $1.26B | $3.29B | $3.12B | · | $2.56B | |
| P/E | -5.5 | -2.9 | · | -1.6 | -1.3 | -1.5 | · | -1.9 | -2.5 | -2.5 | · | -2.1 | -12.6 | -21.5 | · | 2.2 | |
| P/S | 5.7 | 22.1 | · | 47.1 | 36.8 | 42.9 | · | 13.0 | 15.4 | 17.3 | · | 10.6 | 6.7 | 7.0 | · | 1.1 | |
| P/B | 1.8 | 1.8 | · | 1.0 | 0.7 | 0.9 | · | 0.8 | 0.8 | 0.9 | · | 0.8 | 1.8 | 1.6 | · | 1.2 | |
| P / Tangible Book | 1.8 | 1.8 | · | 1.0 | 0.8 | 0.9 | · | 0.9 | 0.9 | 0.9 | · | 0.8 | 1.9 | 1.6 | · | 1.2 | |
| P / Cash Flow | · | -10.9 | · | · | · | -11.5 | · | · | · | -12.6 | · | · | · | -24.8 | · | · | |
| Earnings Yield | -18.2% | -34.9% | · | -63.4% | -79.6% | -65.3% | · | -52.3% | -40.2% | -39.6% | · | -47.7% | -8.0% | -4.6% | · | 44.5% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $69M | $74M | $86M | $1.62B | $1.10B |
| Operating Margin % | -699.2% | -791.3% | -794.0% | 51.6% | 38.4% |
| Net Income | $-438M | $-522M | $-615M | $516M | $529M |
| Diluted EPS | $-3.16 | $-3.83 | $-4.59 | $3.83 | $3.96 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 5.5 | 8.7 | 9.1 | 4.9 | 4.6 |
| Quick Ratio | 5.0 | 7.5 | 8.6 | 4.6 | 3.9 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-397M | $-454M | $-800M | $1.60B | $-69M |
Institutional owners (13F) 255 filers · $1.6B total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
255
Value held
$1.6B
New positions
34
Exited positions
43
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 34 (-42 vs prior Q) | 43 (+16 vs prior Q) | 95 (-25 vs prior Q) | 76 (+35 vs prior Q) | +7.6M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| BlackRock, Inc. | $210,711,705 | 20,678,283 | 13.43% | Shares |
| ARCH Venture Management, LLC | $129,353,521 | 12,694,163 | 8.25% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $117,136,241 | 11,495,215 | 7.47% | Shares |
| SB INVESTMENT ADVISERS (UK) LTD | $111,561,068 | 10,948,093 | 7.11% | Shares |
| STATE STREET CORP | $101,534,699 | 9,964,151 | 6.47% | Shares |
| GSK plc | $87,134,221 | 8,550,954 | 5.55% | Shares |
| VANGUARD GROUP INC | $75,670,133 | 12,548,944 | 4.82% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $65,101,617 | 6,388,775 | 4.15% | Shares |
| Point72 Asset Management, L.P. | $57,744,906 | 5,666,821 | 3.68% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $34,124,708 | 3,348,366 | 2.18% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $31,789,627 | 3,119,421 | 2.03% | Shares |
| ADAR1 Capital Management, LLC | $25,033,539 | 2,456,677 | 1.60% | Shares |
| GOLDMAN SACHS GROUP INC | $24,101,581 | 2,365,219 | 1.54% | Shares |
| FMR LLC | $23,623,417 | 2,318,294 | 1.51% | Shares |
| MORGAN STANLEY | $22,530,881 | 2,211,077 | 1.44% | Shares |
| Nuveen, LLC | $20,206,180 | 1,982,942 | 1.29% | Shares |
| Pictet Asset Management Holding SA | $19,904,290 | 1,953,316 | 1.27% | Shares |
| Boxer Capital Management, LLC | $19,014,540 | 1,866,000 | 1.21% | Shares |
| NORTHERN TRUST CORP | $14,593,762 | 1,432,165 | 0.93% | Shares |
| Hudson Bay Capital Management LP | $13,899,160 | 1,364,000 | 0.89% | Shares |
| GordonMD Global Investments LP | $13,792,695 | 1,353,552 | 0.88% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $13,483,255 | 1,323,185 | 0.86% | Shares |
| BANK OF AMERICA CORP /DE/ | $11,642,473 | 1,142,539 | 0.74% | Shares |
| TWO SIGMA INVESTMENTS, LP | $11,313,213 | 1,110,227 | 0.72% | Shares |
| Sio Capital Management, LLC | $10,957,042 | 1,075,274 | 0.70% | Shares |
| Savvy Advisors, Inc. | $10,604,376 | 1,040,665 | 0.68% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $10,361,844 | 1,016,864 | 0.66% | Shares |
| Soleus Capital Management, L.P. | $10,190,000 | 1,000,000 | 0.65% | Shares |
| CITADEL ADVISORS LLC | $10,101,724 | 991,337 | 0.64% | Shares |
| SUPERSTRING CAPITAL MANAGEMENT LP | $8,699,050 | 853,685 | 0.55% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $8,575,466 | 841,557 | 0.55% | Shares |
| Ensign Peak Advisors, Inc | $8,496,208 | 833,779 | 0.54% | Shares |
| JPMORGAN CHASE & CO | $8,330,957 | 802,597 | 0.53% | Shares |
| ALGERT GLOBAL LLC | $8,202,716 | 804,977 | 0.52% | Shares |
| Saturn V Capital Management LP | $7,852,852 | 770,643 | 0.50% | Shares |
| Bank of New York Mellon Corp | $7,075,671 | 694,374 | 0.45% | Shares |
| Jones Hill Capital LP | $6,717,380 | 659,213 | 0.43% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $6,661,121 | 653,692 | 0.42% | Shares |
| Qube Research & Technologies Ltd | $6,536,742 | 641,486 | 0.42% | Shares |
| Candriam S.C.A. | $6,379,827 | 626,690 | 0.41% | Shares |
| Clearstead Advisors, LLC | $6,197,906 | 608,234 | 0.40% | Shares |
| NORDEA INVESTMENT MANAGEMENT AB | $6,098,079 | 593,776 | 0.39% | Shares |
| PRINCIPAL FINANCIAL GROUP INC | $5,980,490 | 586,898 | 0.38% | Shares |
| AQR CAPITAL MANAGEMENT LLC | $5,924,626 | 581,416 | 0.38% | Shares |
| Weiss Asset Management LP | $5,660,963 | 555,541 | 0.36% | Shares |
| Avidity Partners Management LP | $5,291,667 | 519,300 | 0.34% | Shares |
| Walleye Capital LLC | $5,240,218 | 514,251 | 0.33% | Shares |
| Alta Partners Management Company, L.P. | $5,196,054 | 509,917 | 0.33% | Shares |
| Invesco Ltd. | $4,845,804 | 475,545 | 0.31% | Shares |
| Parkman Healthcare Partners LLC | $4,843,093 | 475,279 | 0.31% | Shares |
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., ARCH Venture Partners IX, L.P., ARCH Venture Partners IX Overage, L.P., ARCH Venture Partners IX, LLC, Robert Nelsen, Keith Crandell, Clinton Bybee ×8 filings | March 3, 2026 | 8.50% | Amendment | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 31 insiders · 13 officers · 17 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Marianne De Backer | President and CEO | April 29, 2026 J | 286,650 | 0 | 3 | $-947,163 |
| Jason O'Byrne | EVP & Chief Financial Officer | March 20, 2026 J | 2,500 | 0 | 3 | $-68,937 |
| Sung Lee | EVP & Chief Financial Officer | March 27, 2024 S | 100,492 | 0 | 0 | $0 |
| Howard Horn | CFO | Feb. 23, 2023 S | 230,712 | 0 | 0 | $0 |
| Johanna Friedl-Naderer | EVP & Chief Operating Officer | March 3, 2023 S | 148,518 | 0 | 0 | $0 |
| Brent Sabatini | SVP, Chief Accounting Officer | June 1, 2026 S | 61,902 | 0 | 5 | $-113,079 |
| Vanina De Verneuil | EVP, General Counsel, Corp Sec | Feb. 25, 2026 S | 112,982 | 0 | 5 | $-217,660 |
| Mark Eisner | EVP and Chief Medical Officer | Feb. 25, 2026 S | 154,024 | 0 | 3 | $-49,513 |
| Ann M. Hanly | EVP & Chief Technology Officer | Feb. 24, 2025 S | 117,901 | 0 | 0 | $0 |
| Phillip Pang | EVP & Chief Medical Officer | Feb. 22, 2024 S | 250,111 | 0 | 0 | $0 |
| Steven J. Rice | Chief Administrative Officer | June 1, 2023 S | 106,840 | 0 | 0 | $0 |
| Herbert Virgin | EVP, Research & CSO | Aug. 9, 2022 M | 262,500 | 0 | 0 | $0 |
| Jay Parrish | Chief Business Officer | April 1, 2021 M | 9,260 | 0 | 0 | $0 |
| Robert J More | Director | Aug. 11, 2026 J | 517,917 | 0 | 0 | $0 |
| Timothy Coughlin | Director | June 9, 2026 A | 16,000 | 0 | 0 | $0 |
| Janet Napolitano | Director | June 1, 2026 S | 21,216 | 0 | 1 | $-30,240 |
| Ramy Farid | Director | May 27, 2026 A | 32,000 | 0 | 0 | $0 |
| Charles Elliott Sigal | Director | May 27, 2026 A | 39,806 | 0 | 0 | $0 |
| Jeffrey S. Hatfield | Director | May 27, 2026 A | 39,806 | 0 | 0 | $0 |
| Norbert W Bischofberger | Director | May 27, 2026 A | 21,333 | 0 | 0 | $0 |
| Vicki L Sato | Director | May 1, 2026 S | 1,078,391 | 0 | 10 | $-1,599,174 |
| Saira Ramasastry | Director | May 30, 2025 A | 22,619 | 0 | 0 | $0 |
| George A Scangos | Director | Feb. 24, 2025 S | 698,239 | 0 | 0 | $0 |
| Robert Nelsen | Director | May 30, 2024 A | 584,148 | 0 | 0 | $0 |
| Robert J Perez | Director | May 22, 2023 A | 15,806 | 0 | 0 | $0 |
| SHARP PHILLIP A | Director | May 22, 2023 A | 121,174 | 0 | 0 | $0 |
| Dipchand Nishar | Director | May 21, 2021 A | 3,374 | 0 | 0 | $0 |
| Kristina Burow | Director | May 21, 2020 A | 1,000,000 | 0 | 0 | $0 |
| Klaus Frueh | Director | Oct. 16, 2019 C | 362,844 | 0 | 0 | $0 |
| Bill & Melinda Gates Foundation | 10% owner | Oct. 16, 2019 C | 2,777,777 | 0 | 0 | $0 |
| Alaska Permanent Fund Corp | 10% owner | Oct. 16, 2019 C | 5,555,556 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 47 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| IDNA · iShares Trust | 1.37% | 330,932 SH | Sept. 11, 2026 | Daily |
| PSCH · Invesco Exchange-Traded Fund Trust … | 0.77% | 122,287 SH | Oct. 1, 2026 | Daily |
| BBC · ETFis Series Trust I | 0.67% | 36,099 NS | July 31, 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.29% | 168,048 NS | July 31, 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.21% | 48,466 SH | Oct. 1, 2026 | Daily |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.12% | 12,019 SH | Oct. 1, 2026 | Daily |
| IBB · iShares Trust | 0.10% | 1,021,218 SH | Sept. 11, 2026 | Daily |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.09% | 221,169 SH | Oct. 1, 2026 | Daily |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0.09% | 18,546 SH | Oct. 1, 2026 | Daily |
| PWS · Pacer Funds Trust | 0.08% | 2,296 NS | July 31, 2026 | N-PORT |
| VIOV · VANGUARD ADMIRAL FUNDS | 0.08% | 152,022 SH | Aug. 19, 2026 | Daily |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.08% | 106,919 SH | Aug. 19, 2026 | Daily |
| VIOO · VANGUARD ADMIRAL FUNDS | 0.07% | 423,304 SH | Aug. 19, 2026 | Daily |
| VIOG · VANGUARD ADMIRAL FUNDS | 0.06% | 59,262 SH | Aug. 19, 2026 | Daily |
| IWM · iShares Trust | 0.04% | 3,144,068 SH | Sept. 11, 2026 | Daily |
| VBK · VANGUARD INDEX FUNDS | 0.04% | 2,019,005 SH | Aug. 19, 2026 | Daily |
| VFMO · VANGUARD WELLINGTON FUND | 0.04% | 79,032 SH | Aug. 19, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.04% | 707,200 SH | Aug. 19, 2026 | Daily |
| RSSL · Global X Funds | 0.03% | 58,849 NS | July 31, 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.03% | 535,641 NS | July 31, 2026 | N-PORT |
| TECB · iShares Trust | 0.03% | 13,104 SH | Sept. 11, 2026 | Daily |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0.02% | 35,521 SH | Oct. 1, 2026 | Daily |
| VB · VANGUARD INDEX FUNDS | 0.02% | 3,484,960 SH | Aug. 19, 2026 | Daily |
| VHT · VANGUARD WORLD FUND | 0.02% | 352,449 SH | Aug. 19, 2026 | Daily |
| ISCG · iShares Trust | 0.02% | 15,668 SH | Sept. 11, 2026 | Daily |
| FHLC · FIDELITY COVINGTON TRUST | 0.01% | 55,806 NS | July 31, 2026 | N-PORT |
| WSML · iShares Trust | 0.01% | 9,191 SH | Sept. 11, 2026 | Daily |
| SMDX · Tidal Trust III | 0.01% | 1,987 NS | July 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.01% | 1,398,053 SH | Aug. 19, 2026 | Daily |
| DXUV · Dimensional ETF Trust | 0.01% | 4,496 NS | July 31, 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.01% | 372,749 NS | July 31, 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.01% | 22,418 NS | July 31, 2026 | N-PORT |
| TILT · FlexShares Trust | 0.00% | 10,879 NS | July 31, 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.00% | 9,821 NS | July 31, 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 39,437 NS | July 31, 2026 | N-PORT |
| IWV · iShares Trust | 0.00% | 41,614 SH | Sept. 10, 2026 | Daily |
| ITOT · iShares Trust | 0.00% | 173,654 SH | Sept. 11, 2026 | Daily |
| DFUS · Dimensional ETF Trust | 0.00% | 45,317 NS | July 31, 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 4,846,948 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 10,300 SH | Aug. 19, 2026 | Daily |
| IJR · iShares Trust | · | 7,406,345 SH | Sept. 10, 2026 | Daily |
| IJT · iShares Trust | · | 472,791 SH | Sept. 9, 2026 | Daily |
| IJS · iShares Trust | · | 635,538 SH | Sept. 8, 2026 | Daily |
| IWN · iShares Trust | · | 1,143,981 SH | Sept. 11, 2026 | Daily |
| XJR · iShares Trust | · | 16,840 SH | Aug. 31, 2026 | Daily |
| ISCB · iShares Trust | · | 5,053 SH | Sept. 11, 2026 | Daily |
| ISCV · iShares Trust | · | 13,735 SH | Sept. 11, 2026 | Daily |
VIR Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 14 analysts
BUY
Median target
$20.00
+79.1%
4 28.6%
Strong Buy
9 64.3%
Buy
1 7.1%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
9 analysts · 2026-09-28Mean target $20.78 +86.0%
← Below all targets
Current price $11.17
Low$15.00
Mean$20.78
High$30.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| VIR | $841M | -1.9 | -7.6% | -638.9% | -51.1% | · |
| ZBIO | $1.98B | -4.3 | 100.0% | -3777.4% | -156.8% | · |
| BHVN | $1.50B | -1.6 | · | · | -310.8% | · |
| PVLA | $1.30B | -28.2 | 65.3% | -1610.6% | -110.1% | · |
| ABSI | $529M | -4.2 | -38.2% | -4113.7% | -63.5% | · |
| AGIO | $1.59B | -3.8 | 48.0% | -764.0% | -32.2% | · |
| SRPT | $2.26B | -3.0 | 15.6% | -32.5% | -57.1% | · |
| GENB | · | · | · | · | · | · |
| NVAX | $1.09B | 2.6 | 64.7% | 39.2% | -977.1% | · |
| NTLA | $1.05B | -2.4 | 16.9% | -609.8% | -59.5% | · |
Latest News Recent headlines mentioning this company
Why a Biotech Fund Opened a New $6 Million Position in Vir Amid a 99% Stock Rally
Nasdaq · 4 months, 1 week ago
Vir Biotechnology's Chairman of the Board Sold 22,000 Company Shares. Here's What That Means for Investors.
Nasdaq · 4 months, 3 weeks ago
Is Vir Biotechnology, Inc. (VIR) A Good Stock To Buy Now?
Yahoo Finance · 5 months ago
Vir Biotechnology (VIR) CEO Sells 73,000 Shares for $664,000
Nasdaq · 5 months, 3 weeks ago
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 5, 2026